Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Frontline Plc Remuneration Information 2021

Dec 8, 2021

6242_rns_2021-12-08_39d3da1c-46fe-4b95-be02-0d5b39233bb4.html

Remuneration Information

Open in viewer

Opens in your device viewer

FRO - Grant of synthetic options

FRO - Grant of synthetic options

Frontline Ltd. ("Frontline" or the "Company") hereby announces that 1,280,000

synthetic options have today been granted to employees and board members. The

synthetic options will have a five-year term expiring December 7, 2026, and will

vest over a three-year vesting period as follows:

* 352,000 of the Synthetic Options will vest on December 7, 2022;

* 352,000 of the Synthetic Options will vest on December 7, 2023; and

* 576,000 of the Synthetic Options will vest on December 7, 2024

The exercise price is NOK 71.-, which shall increase by NOK 5.- on each of

December 7, 2023, and December 7, 2024, and will further be adjusted for any

distribution of dividends made before the relevant synthetic options are

exercised.

The synthetic options will be settled in cash based on the difference between

the market price of the Company's shares and the exercise price on the date of

exercise.

The synthetic options have been granted according to the rules of the Company's

synthetic option scheme approved by the Board of Directors of the Company on

December 7, 2021. Please see the attached forms of notification of transactions

by primary insiders for the Synthetic Options.

December 7, 2021

The Board of Directors

Frontline Ltd.

Hamilton, Bermuda

This notification has been publicly disclosed in accordance with Article 19 of

the Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading

Act.